Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1Phase 2/3 1Phase 2 1

Status

Unknown 6Recruiting 6Completed 5Active not recruiting 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6Observational 5

Sponsor

Cancer Type

Gastrointestinal 5Tumor-Agnostic 1

Conditions

Stomach Neoplasms 4Recurrence 1Margins of Excision 1Advanced Gastric Cancer 1Adenocarcinoma 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Interventional × Gastrectomy × Clear all
NCT05800236 2023-04-05

MICROGAS

University Hospital, Bordeaux

Phase NA Unknown
20 enrolled
Gastrointestinal

Stomach Neoplasms

NCT05707338 2023-01-31

Short-term Outcomes of Laparoscopic Versus Open Gastrectomy With Lymph Node Dissection for Early Gastric Cancer :a Randomized Controlled Study

Sohag University

Phase NA Unknown
40 enrolled
Gastrointestinal

Stomach Neoplasms

NCT04782791 2022-01-11

Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer

Chinese PLA General Hospital

Phase 2 Unknown
30 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02313688 2017-12-11

Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors

West China Hospital

Phase NA Unknown
320 enrolled
Gastrointestinal

Margins of Excision, Recurrence, Stomach Neoplasms

NCT02123407 2014-04-25

Clinical Study on the Harvesting Lymph Nodes With Carbon Nanoparticles for Advanced Gastric Cancer

Peking University

Phase 3 Unknown
30 enrolled
Gastrointestinal

Advanced Gastric Cancer

NCT01523015 2013-02-05

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Medical University of Lublin

Phase 2/3 Unknown
100 enrolled
Tumor-Agnostic

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡